Latin America In Vitro Diagnostics Market Size, Share & Trends Report Analysis By Product (Instruments, Reagents, Software), By Technology (Immunochemistry, Hematology), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology), By End-use, And Segment Forecasts To 2024

Table of Content

Chapter 1. Methodology and Scope
                     1.1. Research Methodology
                     1.2. Research Scope & Assumptions
                     1.3. List of Data Sources
Chapter 2. Executive Summary
                     2.1. Latin America IVD Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Latin America IVD Industry Outlook
                     3.1. Latin America IVD Market Segmentation
                     3.2. Latin America IVD Market Size and Growth Outlook
                     3.3. Latin America IVD Market Dynamics
                          3.3.1. Market Drivers Estimates
                                3.3.1.1. Substantial Increase in Geriatric Population in Latin America
                                3.3.1.2. Considerable Prevalence of Chronic Disease
                                3.3.1.3. Growing Need for Point of Care Facilities.
                          3.3.2. Market Restraint Estimates
                                3.3.2.1. Lesser Rate of Reimbursement
                                3.3.2.2. Stringent Regulatory Background
                     3.4. Market Estimates - Porter’s
                     3.5. Latin America IVD Market PESTEL Estimates, 2015
Chapter 4. Latin America IVD Product Outlook
                     4.1. Latin America IVD Market Share by Product, 2015 & 2024
                     4.2. Instruments
                          4.2.1. Instruments Market Estimates and Forecasts, 2013 - 2024
                     4.3. Reagents
                          4.3.1. Reagents Market Estimates and Forecasts, 2013 - 2024
                     4.4. Software
                          4.4.1. Software Market Estimates and Forecasts, 2013 - 2024
Chapter 5. Latin America IVD Technology Outlook
                     5.1. Latin America IVD Market Share by technology, 2015 & 2024
                     5.2. Immunochemistry
                          5.2.1. Immunochemistry Market Estimates and Forecasts, 2013 - 2024
                     5.3. Hematology
                          5.3.1. Hematology Market Estimates and Forecasts, 2013 - 2024
                     5.4. Clinical Chemistry
                          5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2013 - 2024
                     5.5. Molecular Diagnostics
                          5.5.1. Molecular Diagnostics Market Estimates and Forecasts, 2013 - 2024
                     5.6. Coagulation
                          5.6.1. Coagulation Market Estimates and Forecasts, 2013 - 2024
                     5.7. Microbiology
                          5.7.1. Microbiology Market Estimates and Forecasts, 2013 - 2024
                     5.8. Other Clinical Technology
                          5.8.1. Other Clinical Technology Market Estimates and Forecasts, 2013 - 2024
Chapter 6. Latin America IVD Application Outlook
                     6.1. Latin America IVD Market Share by Application, 2015 & 2024
                     6.2. Infectious Disease
                          6.2.1. Infectious Disease Market Estimates and Forecasts, 2013 - 2024
                     6.3. Diabetes
                          6.3.1. Diabetes Market Estimates and Forecasts, 2013 - 2024
                     6.4. Oncology/Cancer
                          6.4.1. Oncology/Cancer Market Estimates and Forecasts, 2013 - 2024
                     6.5. Cardiology
                          6.5.1. Cardiology Market Estimates and Forecasts, 2013 - 2024
                     6.6. Nephrology
                          6.6.1. Nephrology Market Estimates and Forecasts, 2013 - 2024
                     6.7. Autoimmune Diseases
                          6.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2013 - 2024
                     6.8. Drug Testing
                          6.8.1. Drug Testing Market Estimates and Forecasts, 2013 - 2024
                     6.9. Others
                          6.9.1. Others Market Estimates and Forecasts, 2013 - 2024
Chapter 7. Latin America IVD End-use Outlook
                     7.1. Latin America IVD Market Share by End-use, 2015 & 2024
                     7.2. Hospitals
                          7.2.1. Hospitals Market Estimates and Forecasts, 2013 - 2024
                     7.3. Laboratory
                          7.3.1. Laboratory Market Estimates and Forecasts, 2013 - 2024
                     7.4. Home Care
                          7.4.1. Home Care Market Estimates and Forecasts, 2013 - 2024
                     7.5. Others
                          7.5.1. Others Market Estimates and Forecasts, 2013 - 2024
Chapter 8. Latin America IVD Regional Outlook
                     8.1. Latin America Market Share by Region, 2015 & 2024
                     8.2. Brazil
                          8.2.1. Brazil IVD Market, 2013 - 2024 (USD Million)
                     8.3. Mexico
                          8.3.1. Mexico IVD Market, 2013 - 2024 (USD Million)
                     8.4. Peru
                          8.4.1. Peru IVD Market, 2013 - 2024 (USD Million)
                     8.5. Chile
                          8.5.1. Chile IVD Market, 2013 - 2024 (USD Million)
                     8.6. Colombia
                          8.6.1. Colombia IVD Market, 2013 - 2024 (USD Million)
                     8.7. Argentina
                          8.7.1. Argentina IVD Market, 2013 - 2024 (USD Million)
                     8.8. Venezuela
                          8.8.1. Venezuela IVD Market, 2013 - 2024 (USD Million)
Chapter 9. Competitive Landscape
                     9.1. Becton Dickinson
                          9.1.1. Company Overview
                          9.1.2. Financial Performance
                          9.1.3. Product Benchmarking
                          9.1.4. Strategic Initiatives
                     9.2. bioMerieux
                          9.2.1. Company Overview
                          9.2.2. Financial Performance
                          9.2.3. Product Benchmarking
                          9.2.4. Strategic Initiatives
                     9.3. Abbott Laboratories
                          9.3.1. Company Overview
                          9.3.2. Financial Performance
                          9.3.3. Product Benchmarking
                          9.3.4. Strategic Initiatives
                     9.4. Quidel Corporation
                          9.4.1. Company Overview
                          9.4.2. Financial Performance
                          9.4.3. Product Benchmarking
                          9.4.4. Strategic Initiatives
                     9.5. Alere, Inc.
                          9.5.1. Company Overview
                          9.5.2. Financial Performance
                          9.5.3. Product Benchmarking
                          9.5.4. Strategic Initiatives
                     9.6. OraSure Technologies
                          9.6.1. Company Overview
                          9.6.2. Financial Performance
                          9.6.3. Product Benchmarking
                          9.6.4. Strategic Initiatives
                     9.7. Hologic (Gen Probe)
                          9.7.1. Company Overview
                          9.7.2. Financial Performance
                          9.7.3. Product Benchmarking
                          9.7.4. Strategic Initiatives
                     9.8. Cepheid Inc.
                          9.8.1. Company Overview
                          9.8.2. Financial Performance
                          9.8.3. Product Benchmarking
                          9.8.4. Strategic Initiatives
                     9.9. Qiagen N.V.
                          9.9.1. Company Overview
                          9.9.2. Financial Performance
                          9.9.3. Product Benchmarking
                          9.9.4. Strategic Initiatives
                     9.10. Roche Diagnostics
                          9.10.1. Company Overview
                          9.10.2. Financial Performance
                          9.10.3. Product Benchmarking
                          9.10.4. Strategic Initiatives
                     9.11. Siemens Healthcare
                          9.11.1. Company Overview
                          9.11.2. Financial Performance
                          9.11.3. Product Benchmarking
                          9.11.4. Strategic Initiatives
                     9.12. Bio-Rad Laboratories
                          9.12.1. Company Overview
                          9.12.2. Financial Performance
                          9.12.3. Product Benchmarking
                          9.12.4. Strategic Initiatives

List of Tables

TABLE 1 Latin America IVD market, - Industry Summary & Key Buying Criteria, 2013 - 2024
TABLE 2 Latin America IVD market, by product, 2013 - 2024 (USD million)
TABLE 3 Latin America IVD market, by application, 2013 - 2024 (USD million)
TABLE 4 Latin America IVD market, by technology, 2013 - 2024 (USD million)
TABLE 5 Latin America IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 6 Latin America IVD market, by region, 2013 - 2024 (USD million)
TABLE 7 Latin America IVD Market, - Key market driver analysis
TABLE 8 Latin America IVD Market, - Key market restraint analysis
TABLE 9 Brazil IVD market, by product, 2013 - 2024 (USD million)
TABLE 10 Brazil IVD market, by application, 2013 - 2024 (USD million)
TABLE 11 Brazil IVD market, by technology, 2013 - 2024 (USD million)
TABLE 12 Brazil IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 13 Mexico IVD market, by product, 2013 - 2024 (USD million)
TABLE 14 Mexico IVD market, by application, 2013 - 2024 (USD million)
TABLE 15 Mexico IVD market, by technology, 2013 - 2024 (USD million)
TABLE 16 Mexico IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 17 Peru IVD market, by product, 2013 - 2024 (USD million)
TABLE 18 Peru IVD market, by application, 2013 - 2024 (USD million)
TABLE 19 Peru IVD market, by technology, 2013 - 2024 (USD million)
TABLE 20 Peru IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 21 Chile IVD market, by product, 2013 - 2024 (USD million)
TABLE 22 Chile IVD market, by application, 2013 - 2024 (USD million)
TABLE 23 Chile IVD market, by technology, 2013 - 2024 (USD million)
TABLE 24 Chile IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 25 Colombia IVD market, by product, 2013 - 2024 (USD million)
TABLE 26 Colombia IVD market, by application, 2013 - 2024 (USD million)
TABLE 27 Colombia IVD market, by technology, 2013 - 2024 (USD million)
TABLE 28 Colombia IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 29 Argentina IVD market, by product, 2013 - 2024 (USD million)
TABLE 30 Argentina IVD market, by application, 2013 - 2024 (USD million)
TABLE 31 Argentina IVD market, by technology, 2013 - 2024 (USD million)
TABLE 32 Argentina IVD market, by end-use, 2013 - 2024 (USD million)
TABLE 33 Venezuela IVD market, by product, 2013 - 2024 (USD million)
TABLE 34 Venezuela IVD market, by application, 2013 - 2024 (USD million)
TABLE 35 Venezuela IVD market, by technology, 2013 - 2024 (USD million)
TABLE 36 Venezuela IVD market, by end-use, 2013 - 2024 (USD million)

List of Figures

FIG. 1 Latin America IVD: Market segmentation
FIG. 2 Latin America IVD Market Revenue, 2013 - 2024 (USD million)
FIG. 3 Latin America IVD Market Market Dynamics
FIG. 4 Key Opportunities Prioritized
FIG. 5 Latin America IVD Market - Porter’s Analysis
FIG. 6 Latin America IVD Market - PESTEL Analysis
FIG. 7 Latin America IVD market share, by product, 2015 & 2024
FIG. 8 IVD instruments market, 2013 - 2024 (USD million)
FIG. 9 IVD reagents market, 2013 - 2024 (USD million)
FIG. 10 IVD software market, 2013 - 2024 (USD million)
FIG. 11 IVD data management market, 2013 - 2024 (USD million)
FIG. 12 Latin America IVD market share, by technology, 2015 & 2024
FIG. 13 IVD immunology market, 2013 - 2024 (USD million)
FIG. 14 IVD hematology market, 2013 - 2024 (USD million)
FIG. 15 IVD clinical chemistry market, 2013 - 2024 (USD million)
FIG. 16 IVD molecular diagnostics market, 2013 - 2024 (USD million)
FIG. 17 IVD coagulation market, 2013 - 2024 (USD million)
FIG. 18 IVD microbiology market, 2013 - 2024 (USD million)
FIG. 19 IVD others market, 2013 - 2024 (USD million)
FIG. 20 Latin America IVD market share, byend-use, 2015 & 2024
FIG. 21 IVD Hospitals market, 2013 - 2024 (USD million)
FIG. 22 IVD laboratory market, 2013 - 2024 (USD million)
FIG. 23 IVD home care market, 2013 - 2024 (USD million)
FIG. 24 IVD others market, 2013 - 2024 (USD million)
FIG. 25 Latin America IVD market share, by region, 2015 & 2024
FIG. 26 IVD Brazil market, 2013 - 2024 (USD million)
FIG. 27 IVD Mexico market, 2013 - 2024 (USD million)
FIG. 28 IVD Peru market 2013 - 2024 (USD million)
FIG. 29 IVD Chile market, 2013 - 2024 (USD million)
FIG. 30 IVD Colombia market, 2013 - 2024 (USD million)
FIG. 31 IVD Argentina market, 2013 - 2024 (USD million)
FIG. 32 IVD Venezuela market, 2013 - 2024 (USD million)